Xcout Intel
Atomwise Inc.
Atomwise Inc. is an artificial intelligence-driven drug development company founded in 2012 and based in San Francisco, California. The company utilizes advanced AI technologies, such as its AtomNet PoseRanker, to discover novel medicines and accelerate pharmaceutical research.
Subscribe to see Atomwise Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Atomwise Inc. at a glance
Atomwise Inc. is a company headquartered in United States. It has raised at least $218.8M across the 3 funding rounds on record. Its most recent funding round raised $44.3M in March 2024. Xcout tracks 8 named people at Atomwise Inc., including Stephen Worland (Chief Executive Officer).
Atomwise Inc. leadership
- Stephen WorlandChief Executive Officer
- Gannon ConnorVP, Corporate Development and Operations
- Mark SabatVP, Medicinal Chemistry
- Pamela TsurudaVP, Biology
- Adam SeabrookDirector
- Mike Varney, PhDDirector
2 more named people on record for Atomwise Inc., with roles, board committees and tenure — see the full roster →
Atomwise Inc. funding rounds
At least $218.8M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $44.3M | — | |
| SEC Form D filing | $123M | — | |
| Series A | $51.5M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Atomwise Inc. competitors
A few of Atomwise Inc.'s closest competitors — see the full list of competitors and alternatives →
Atomic AI is a biotechnology research company specializing in RNA drug discovery utilizing atomic precision. Headquartered in San Francisco, California, the company combines machine learning and biology to develop advanced therapeutics.
Deep Apple Therapeutics, Inc. is a life sciences company leveraging deep learning-driven structure-based drug discovery, located in South San Francisco, California.
Numerion Labs, headquartered in San Francisco, CA, USA, specializes in AI-based drug discovery services. The company employs a world-class team of scientists and engineers to redefine how small-molecule drugs are discovered using artificial intelligence.
Insitro is a physical artificial intelligence company headquartered in South San Francisco, California, that uses machine learning and data at scale to build a different kind of drug company.
Atinary is an artificial intelligence company with operations in Silicon Valley and Switzerland, featuring headquarters in Menlo Park, California. The company provides a code-free AI platform that accelerates research, development, and discovery in molecular science and chemistry.
Get Atomwise Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Atomwise Inc. in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 3 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access